摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

1,1-二氯-3-甲氧基丙烷 | 2806-74-8

中文名称
1,1-二氯-3-甲氧基丙烷
中文别名
——
英文名称
1,1-Dichloro-3-methoxypropane
英文别名
(3,3-dichloro-propyl)-methyl ether;(3,3-Dichlor-propyl)-methyl-aether;1,1-Dichlor-3-methoxy-propan
1,1-二氯-3-甲氧基丙烷化学式
CAS
2806-74-8
化学式
C4H8Cl2O
mdl
——
分子量
143.013
InChiKey
YGSHJAGOTBMQJN-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    1.8
  • 重原子数:
    7
  • 可旋转键数:
    3
  • 环数:
    0.0
  • sp3杂化的碳原子比例:
    1.0
  • 拓扑面积:
    9.2
  • 氢给体数:
    0
  • 氢受体数:
    1

反应信息

  • 作为反应物:
    描述:
    1,1-二氯-3-甲氧基丙烷亚甲基环丙烷sodium hexamethyldisilazane 作用下, 以 正戊烷 为溶剂, 反应 10.0h, 以53%的产率得到1-Chloro-1-(2-methoxyethyl)spiropentane
    参考文献:
    名称:
    Branched triangulanes: general strategy of synthesis
    摘要:
    A general synthetic strategy for the construction of branched triangulanes (BTs) (spirocondensed polycyclopropanes) has been elaborated. The synthetic utility of the method is illustrated by the synthesis of some members of the [5]- and [6]BT families, especially 13a,b and 14. An independent synthesis of the perspirocyclopropanated spiropentane 14 is also presented.
    DOI:
    10.1021/jo00028a054
  • 作为产物:
    描述:
    3-甲氧基丙醛吡啶五氯化磷 作用下, 以 二氯甲烷 为溶剂, 反应 10.0h, 以55%的产率得到1,1-二氯-3-甲氧基丙烷
    参考文献:
    名称:
    Branched triangulanes: general strategy of synthesis
    摘要:
    A general synthetic strategy for the construction of branched triangulanes (BTs) (spirocondensed polycyclopropanes) has been elaborated. The synthetic utility of the method is illustrated by the synthesis of some members of the [5]- and [6]BT families, especially 13a,b and 14. An independent synthesis of the perspirocyclopropanated spiropentane 14 is also presented.
    DOI:
    10.1021/jo00028a054
点击查看最新优质反应信息

文献信息

  • Potassium channel openers
    申请人:——
    公开号:US20020028836A1
    公开(公告)日:2002-03-07
    Compounds of formula I: 1 are useful in treating diseases prevented by or ameliorated with potassium channel openers. Also disclosed are potassium channel opening compositions and a method of opening potassium channels in a mammal.
    公式I的化合物: 1 在治疗通过或用钾通道开放剂预防或改善的疾病中是有用的。还公开了钾通道开放组合物以及在哺乳动物中开放钾通道的方法。
  • Aminal Diones as potassium channel openers
    申请人:——
    公开号:US20020147230A1
    公开(公告)日:2002-10-10
    Compounds of formula (I) 1 may be useful in treating diseases prevented by or ameliorated with potassium channel openers. Also disclosed are potassium channel opening compositions and a method of opening potassium channels in a mammal.
    化合物的化学式(I)可能在治疗由钾通道开放剂预防或改善的疾病中有用。还公开了钾通道开放组合物和在哺乳动物中开放钾通道的方法。
  • Aminal diones as potassium channel openers
    申请人:——
    公开号:US20020165264A1
    公开(公告)日:2002-11-07
    Compounds of formula (I) 1 may be useful in treating diseases prevented by or ameliorated with potassium channel openers. Also disclosed are potassium channel opening compositions and a method of opening potassium channels in a mammal.
    化合物式(I)1可能有助于治疗通过钾通道开放剂预防或改善的疾病。此外,还披露了钾通道开放组合物和在哺乳动物中开放钾通道的方法。
  • DE898588
    申请人:——
    公开号:——
    公开(公告)日:——
  • POTASSIUM CHANNEL OPENERS
    申请人:Abbott Laboratories
    公开号:EP1198456A2
    公开(公告)日:2002-04-24
查看更多